# Exogenous Ketone Esters for Refractory Status Epileptics

> **NCT05674552** · PHASE2,PHASE3 · RECRUITING · sponsor: **Sohag University** · enrollment: 50 (estimated)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** Exogenous ketone ester

## Key facts

- **NCT ID:** NCT05674552
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-10
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674552, "Exogenous Ketone Esters for Refractory Status Epileptics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05674552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*